Researchers at the UNC School of Medicine’s International Center for the Advancement of Translational Science and the Institute for Global Health and Infectious Diseases have developed a new approach for the detailed evaluation of HIV infection throughout the entire male genital tract, HIV acquisition via the penis and the efficient prevention of penile HIV infection. … Read more

HIV virus eradication is a complex health challenge due to its long-lived persistence and how it hides in latently infected cells that escape the body’s immune system. Effective HIV treatments have decreased the likelihood of someone developing AIDS, while helping individuals live long and healthy lives without transmission to sexual partners. But for individuals with long-standing … Read more

Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Dr. Myron “Mike” Cohen, director of the UNC Institute for Global Health & Infectious Diseases is the architect and principal investigator of … Read more

Weiming Tang, PhD, promotes social innovations in health, using crowdsourcing that inspires the creation of equitable and effective health services, as well as pay-it-forward approaches that show how kindness can be contagious in healthcare. As co-director of Project China, Weiming has co-authored over 200 peer-reviewed publications. And when it comes to success, he says “patience” … Read more

Angela Wahl, PhD, a member of the Institute for Global Health & Infectious Diseases (IGHID), the International Center for the Advancement for Translational Science, and assistant professor in the division of infectious diseases has received a $3.2 million R01 award to study the role of microglia in HIV latency and persistence in the brain. Over … Read more

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). “HIV infection … Read more

Michael Sciaudone, MD, an infectious diseases specialist at UNC, has won a 2021 postdoctoral fellowship in tropical infectious diseases from the Burroughs Wellcome Fund-American Society of Tropical Medicine & Hygiene (ASTMH). Three of the coveted fellowships are awarded nationally each year, funding research focused on low and low-middle income countries. Sciaudone will use the two-year … Read more

The National Institutes of Health has awarded approximately $53 million in annual funding over the next five years to 10 research organizations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research program, initiated in 2011, further expand the initiative’s 2016 renewal from six institutions to … Read more

HIV-related mortality has decreased since 1996 due to improved treatments and evolving care guidelines, but the extent to which persons entering HIV care have a higher risk for death over the following years, compared with peers in the general population, has been unclear. Joseph Eron, MD, the Herman and Louise Smith Distinguished Professor of Medicine … Read more

In the summer of 2001, Shani Morgan was a few months pregnant and in prison, where she learned that she had HIV. She’d been sent from jail to Bragg Street Women’s Prison in Raleigh for better monitoring and medical treatment. What she remembers most about being treated by her UNC doctor, Becky White, MD, MPH, … Read more

The Infectious Diseases Society of America, the nation’s leading infectious diseases professional society, has elected the Institute’s Joseph Eron, MD; Anne Lachiewicz, MD, MPH; and Christopher Hurt, MD, to its latest cohort of Fellows of IDSA. As the highest honor in the field of infectious diseases, IDSA fellowships recognize those who have achieved professional excellence … Read more

AIDS Clinical Trials Group, co-led by UNC’s Joseph Eron, MD, also re-funded for seven years Myron S. Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and Wafaa El-Sadr, MD, MPH, MPA, director of ICAP at Columbia University, have received a seven-year award from the National Institutes of Health for leadership of … Read more

  The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant women at four research sites … Read more

ACTG names second new award for former UNC neurology professor, Kevin Robertson The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, and Kevin Robertson, … Read more

Study led by female investigators enrolled women living with HIV in sub-Saharan Africa A long-acting injectable drug, cabotegravir, is safe and more effective than a daily pill in preventing HIV acquisition, according to results from a study of 3,127 cisgender women in sub-Saharan Africa. Led by UNC researchers beginning in November 2017, the study showed … Read more

The HIV Medicine Association, or HIVMA, has honored UNC infectious diseases professor Ada Adimora, MD, MPH, with its 2020 Clinical Educator Award. The award, presented during the annual IDWeek conference, recognizes Adimora’s “extraordinary contributions to advancing clinical education, with a focus on disseminating her research on the drivers of HIV-related racial disparities.” Adimora is the … Read more

Cell Microsystems and UNC’s HIV Cure Center will continue their work on developing an automated assay that can measure single cells for latent HIV, thanks to a two-year, $1.65 million contract from the National Institutes of Health. The new contract, a highly competitive phase II Small Business Innovation Research award, affirms the partners’ success resulting … Read more

Black women in the southern United States are less likely to seek HIV prevention and treatment services because they don’t trust the health care system, according to a study in the September/October issue of The Journal of the Association of Nurses in AIDS Care (JANAC) by Schenita Randolph, PhD, MPH, at Duke University School of Nursing. … Read more

A team of UNC researchers are partnering with colleagues at four institutions in Africa to study HIV-associated malignancies. With a five-year, $6 million grant from the NIH’s National Cancer Institute, the research consortium will look at screening and diagnosing innovations for three cancers common to people with HIV: Kaposi sarcoma, cervical cancer and lymphoma. Leading … Read more

  Large-scale study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, shows higher efficacy than daily oral pill.   The decades-long search for a vaccine to prevent HIV reached a new milestone as results from HPTN 083, a global large-scale study, show that the long-acting drug cabotegravir (CAB LA) … Read more